We have received a limited supply of Indrepta Plus and have offered it first to donors to our crowdfunding effort. It’s important we try this on a select group before manafacturing a large batch, as if it does not have any additional benefit to the regular Indrepta Plus, it will not merit the extra cost to manufacture it. Over the next few weeks we hope to have some more anecdotal data to share with you.